Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
World Journal of Gastroenterology|September 9, 2016
Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancerVincenzo Sforza, Erika Martinelli, Fortunato Ciardiello, et al.
Critical Reviews in Oncology/Hematology|April 8, 2022
Immunotherapy for head and neck cancer: Present and futureMorena Fasano, Carminia Maria Della Corte, Raimondo Di Liello, et al.
World Journal of Gastroenterology|August 3, 2017
Present and future of metastatic colorectal cancer treatment: A review of new candidate targetsGiulia Martini, Teresa Troiani, Claudia Cardone, et al.
Frontiers in Oncology|June 26, 2023
Case report of unusual synchronous anal and rectal squamous cell carcinoma: clinical and therapeutic lessonDavide Ciardiello, Sara Del Tufo, Paola Parente, et al.
Cancers|April 30, 2021
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal CancerDavide Ciardiello, Giulia Martini, Vincenzo Famiglietti, et al.
Cancers|August 26, 2022
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13, 1941Davide Ciardiello, Giulia Martini, Vincenzo Famiglietti, et al.
Scientific Reports|January 4, 2024
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLCCaterina De Rosa, Viviana De Rosa, Concetta Tuccillo, et al.
Clinical Colorectal Cancer|July 6, 2021
Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical DataPasquale Vitale, Nicoletta Zanaletti, Vincenzo Famiglietti, et al.
ESMO Open|February 2, 2018
Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical caseErika Martinelli, Teresa Troiani, Vincenzo Sforza, et al.
Cancers|September 28, 2021
How Immunotherapy Has Changed the Continuum of Care in Hepatocellular CarcinomaGiulia Martini, Davide Ciardiello, Fernando Paragliola, et al.
Pageof 9